Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU

NCT05833282 is registered in ClinicalTrials.gov with Tourcoing Hospital as lead sponsor.

NCT NCT05833282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05833282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU
Lead sponsor
Tourcoing Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
June 30, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistance, multiple, bacterial